CClinicalTrials.gg
CompletedNCT05401799Updated May 18, 2025

BURT Efficacy in Improving Upper Extremity Strength and Function During Post-stroke Inpatient Rehabilitation

An interventional study of BURT and Other Occupational Therapy in Stroke, Stroke, Acute and Cerebral Vascular Accident, sponsored by Sunnyview Rehabilitation Hospital. Completed at 2 sites in United States. Open to participants aged 18 Years to 115 Years. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Sunnyview Rehabilitation Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Feb 2025, 1 year 7 months ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 115 Years
Sex
All
01

Study summary

The Barrett Upper Extremity Robot (BURT) is an FDA-approved upper extremity robot that assists patients with both passive and active range of motion while providing adjustable resistance (Barrett_Medical. Robotic Assist Rehabilitation Made Easy. https://medical.barrett.com/). Activities are directed by therapists and encourage patient involvement through video game activities providing active proprioceptive, vibrational, visual and auditory feedback. Engaging and colorful games are beneficial in holding patients' interest, and gravity assistance may also allow for increased repetition in the face of patient fatigue.

In this prospective study, the investigators will determine if a standardized BURT Upper Extremity (UE) program can be consistently implemented within an acute inpatient rehabilitation facility (IRF). In addition, the investigators will see if patients who receive BURT have improved UE mobility and function as a result. The investigators will also study the perceived enjoyment and value of the intervention by patients, and perceived value by therapists.

Because BURT therapy is able to provide more repetitions of upper extremity movement in a shorter length of time than conventional therapy, the investigators hypothesize that patients who participate in neuro re-education activities using BURT will achieve greater improvements in strength, upper extremity function, fine motor coordination, activities of daily living and mobility during their time in an IRF than patients receiving conventional therapy.

In this study, eligible patients admitted to Sunnyview Rehabilitation Hospital (SRH) for rehabilitation following stroke will be randomized to receive conventional or BURT therapy. Meaningful clinical benchmarks for upper extremity function, tone, fine motor coordination, activities of daily living and mobility will be assessed using the Upper Extremity Motor Assessment Scale (UE-MAS)(Zelter, 2010), manual muscle testing (MMT), Modified Ashworth Scale (MAS) (Figueiredo, 2011) and the 9-hole peg test (9HPT)(Figueiredo, 2011). The investigators also hypothesize that patients in the BURT cohort will report greater value/usefulness and interest/enjoyment.

02

Conditions studied

  • Stroke
  • Stroke, Acute
  • Cerebral Vascular Accident
  • Cerebral Vascular Accident (CVA)/Stroke

Browse trials for

Keywords

  • BURT
  • Upper extremity function
  • Inpatient rehabilitation
  • Upper extremity robotics
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 82 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Sunnyview Rehabilitation Hospital is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 115 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Inpatient at Sunnyview Rehabilitation Hospital
  • >/= 18 years
  • Unilateral stroke
  • UE paresis affected arm with 3-/5 or less manual muscle testing throughout

Exclusion criteria

Exclusion Criteria:

>30 days post stroke

  • Severe Neglect
  • Bilateral stroke
  • Prior stroke with residual deficits
  • Patients receiving prism adaptation treatment
  • Comorbid neurological disorders
  • Upper limb comorbidities that could limit functional improvement (UE arthritis pain, UE fracture, fixed contracture not allowing for proper device alignment)
  • Severe shoulder subluxation that cannot be accommodated by the device
  • Severe osteoporosis
  • Unable to follow simple directions
  • Unable to tolerate sitting 30 minutes
  • Expected length of stay (LOS) \< 15 days.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Active comparator
    Conventional Upper Extremity Neuroeducation

    74 patients will receive the standard occupational therapy sessions that they would normally receive during their IRF stay. UE neuroeducation sessions are typically focused on improving strength and mobility of the upper arm. Clinicians will not be given instructions on how to run their sessions, however they will not be allowed to use BURT. Other devices that would normally be used during neuro-educational sessions (including X-cite, electrical stimulation and RT-300) will be allowed for use in this group. The therapists will track the activity, level of assistance and time provided in a tracking sheet, as well as document any adverse events that may occur

    Procedure: Other Occupational Therapy

  • Experimental
    BURT Upper Extremity

    As part of routine therapy, 74 patients will receive up to 5 sessions per week of BURT UE therapy in place of conventional neuro re-education. Patients in this arm of the study will receive any conventional therapy during the remainder of their treatment sessions. When using BURT, therapists will track the activity, level of assistance and time provided in a tracking sheet, as well as document any adverse events that may occur.

    Device: BURT · Procedure: Other Occupational Therapy

Interventions

  • DeviceBURT

    Use of Barrett Upper extremity Robot (BURT) to improve strength and mobility of hemiplegic upper extremity.

  • ProcedureOther Occupational Therapy

    Standard occupational therapy sessions will be 60-90 minutes a day and are UE neuroeducation sessions are typically focused on improving strength and mobility of the hemipelagic arm.

06

What researchers measure

Primary outcomes

  1. UE Motor Assessment Scale (UE-MAS)

    Used to assess motor functions in the affected upper extremity following a stroke. This evaluation uses task-oriented techniques instead of isolated movement patterns.

    Time frame: T2(Day 20-23) - T0 (Day 4-6)

  2. UE Motor Assessment Scale (UE-MAS)

    Used to assess motor functions in the affected upper extremity following a stroke. This evaluation uses task-oriented techniques instead of isolated movement patterns.

    Time frame: T1 (Day 12-14) - T0 (Day 4-6)

  3. Manual Muscle Testing (MMT)

    Used to assess the strength in a persons upper extremity based on various planes of movement. This is the most commonly used strength assessment.

    Time frame: T2(Day 20-23) - T0 (Day 4-6)

  4. Manual Muscle Testing (MMT)

    Used to assess the strength in a persons upper extremity based on various planes of movement. This is the most commonly used strength assessment.

    Time frame: T1 (Day 12-14) - T0 (Day 4-6)

  5. Modified Ashworth Scale (MAS)

    The modified Ashworth Scale is the primary measure for muscle spasticity in the upper extremities for patients with neurological conditions.

    Time frame: T2(Day 20-23) - T0 (Day 4-6)

  6. Modified Ashworth Scale (MAS)

    The modified Ashworth Scale is the primary measure for muscle spasticity in the upper extremities for patients with neurological conditions.

    Time frame: T1 (Day 12-14) - T0 (Day 4-6)

  7. 9 Hole Peg Test (9HPT)

    The 9HPT is a standardized test that measures manual dexterity.

    Time frame: T2(Day 20-23) - T0 (Day 4-6)

  8. 9 Hole Peg Test (9HPT)

    The 9HPT is a standardized test that measures manual dexterity.

    Time frame: T1 (Day 12-14) - T0 (Day 4-6)

Secondary outcomes

  1. GG Scores for Self-Care Items

    standardized assessments of functional independence for feeding, bathing, toileting, footwear, upper and lower body dressing and oral hygiene.

    Time frame: Change from admission to discharge, up to 55 days

  2. GG Scores for Mobility items

    standardized assessments of functional independence for bed mobility and transfers.

    Time frame: Change from admission to discharge, up to 55 days

07

Study locations

2 sites
  • Gaylord Hospital
    Wallingford, Connecticut 06492, United States
  • Sunnyview Rehabilitation Hospital
    Schenectady, New York 12308, United States
08

References and documents

Publications

  • Barrett_Medical. Robotic Assist Rehabilitation Made Easy. https://medical.barrett.com/
  • Zelter L. 2010. Motor Assessment Scale (MAS). https://strokengine.ca/en/assessments/motor-assessment-scale-mas/#:~:text=The%20Motor%20Assessment%20Scale%20(MAS,leakage%20from%20a%20blood%20vessel.
  • Figueiredo S ZL. 2011. Modified Ashworth Scale. https://strokengine.ca/en/assessments/modified-ashworth-scale/
  • Figueiredo S. 2011. Nine Hole Peg Test (NHPT). https://strokengine.ca/en/assessments/nine-hole-peg-test-nhpt/

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05401799
Lead sponsor
Sunnyview Rehabilitation Hospital
Collaborators
Gaylord Hospital
Responsible party
Casey Cowan (Occupational Therapist, Sunnyview Rehabilitation Hospital) — Principal investigator
First posted
Jun 2, 2022
Start date
Sep 1, 2022
Primary completion
Feb 17, 2025
Completion
Feb 17, 2025
Last update
May 18, 2025

Study contacts

Casey Cowan, MS OTR/L
principal investigator · Sunnyview Rehabilitation Hospital
Emily Steenburgh, MS OTR/L
principal investigator · Sunnyview Rehabilitation Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion